Journal articlePreclinical

Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity

Protein and peptide letters, 2018. Vyunova TV, Andreeva L, Shevchenko K and 1 others.

Study type

Journal article

Subjects

Animal / preclinical (no Humans MeSH term)

Journal

Protein and peptide letters

Published

2018

PubMed

PMID 30255741 ↗

DOI

10.2174/0929866525666180925144642 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Selank →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Amino Acid SequenceAnimalsAnti-Anxiety AgentsMaleNootropic AgentsOligopeptidesRatsgamma-Aminobutyric Acid

Other papers on Selank

Journal article · 2021

The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress

Journal article · 2021

Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page